Cargando…

Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo

BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endotheli...

Descripción completa

Detalles Bibliográficos
Autores principales: Genduso, Sandra, Freytag, Vera, Schetler, Daniela, Kirchner, Lennart, Schiecke, Alina, Maar, Hanna, Wicklein, Daniel, Gebauer, Florian, Bröker, Katharina, Stürken, Christine, Milde-Langosch, Karin, Oliveira-Ferrer, Leticia, Ricklefs, Franz L., Ewald, Florian, Wolters-Eisfeld, Gerrit, Riecken, Kristoffer, Unrau, Ludmilla, Krause, Linda, Bohnenberger, Hanibal, Offermann, Anne, Perner, Sven, Sebens, Susanne, Lamszus, Katrin, Diehl, Linda, Linder, Stefan, Jücker, Manfred, Schumacher, Udo, Lange, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022201/
https://www.ncbi.nlm.nih.gov/pubmed/36932441
http://dx.doi.org/10.1186/s13045-023-01413-9
_version_ 1784908677813108736
author Genduso, Sandra
Freytag, Vera
Schetler, Daniela
Kirchner, Lennart
Schiecke, Alina
Maar, Hanna
Wicklein, Daniel
Gebauer, Florian
Bröker, Katharina
Stürken, Christine
Milde-Langosch, Karin
Oliveira-Ferrer, Leticia
Ricklefs, Franz L.
Ewald, Florian
Wolters-Eisfeld, Gerrit
Riecken, Kristoffer
Unrau, Ludmilla
Krause, Linda
Bohnenberger, Hanibal
Offermann, Anne
Perner, Sven
Sebens, Susanne
Lamszus, Katrin
Diehl, Linda
Linder, Stefan
Jücker, Manfred
Schumacher, Udo
Lange, Tobias
author_facet Genduso, Sandra
Freytag, Vera
Schetler, Daniela
Kirchner, Lennart
Schiecke, Alina
Maar, Hanna
Wicklein, Daniel
Gebauer, Florian
Bröker, Katharina
Stürken, Christine
Milde-Langosch, Karin
Oliveira-Ferrer, Leticia
Ricklefs, Franz L.
Ewald, Florian
Wolters-Eisfeld, Gerrit
Riecken, Kristoffer
Unrau, Ludmilla
Krause, Linda
Bohnenberger, Hanibal
Offermann, Anne
Perner, Sven
Sebens, Susanne
Lamszus, Katrin
Diehl, Linda
Linder, Stefan
Jücker, Manfred
Schumacher, Udo
Lange, Tobias
author_sort Genduso, Sandra
collection PubMed
description BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endothelial cells within the tumor stroma for regulating tumor growth by shaping the local and systemic immune environment. METHODS: We used several preclinical mouse models for different solid human cancer types (xenograft and syngeneic) to explore the role of ITGB4 (shRNA-mediated knockdown in tumor cells) and E-/P-selectins (knockout in mice) for tumor growth; effects on apoptosis, proliferation and intratumoral signaling pathways were determined by histological and biochemical methods and 3D in vitro experiments; changes in the intratumoral and systemic immune cell composition were determined by flow cytometry and immunohistochemistry; chemokine levels and their attracting potential were measured by ELISA and 3D invasion assays. RESULTS: We observed a very robust synergism between ITGB4 and E-/P-selectin for the regulation of tumor growth, accompanied by an increased recruitment of CD11b(+) Gr-1(Hi) cells with low granularity (i.e., myeloid-derived suppressor cells, MDSCs) specifically into ITGB4-depleted tumors. ITGB4-depleted tumors undergo apoptosis and actively attract MDSCs, well-known to promote tumor growth in several cancers, via increased secretion of different chemokines. MDSC trafficking into tumors crucially depends on E-/P-selectin expression. Analyses of clinical samples confirmed an inverse relationship between ITGB4 expression in tumors and number of tumor-infiltrating leukocytes. CONCLUSIONS: These findings suggest a distinct vulnerability of ITGB4(Lo) tumors for MDSC-directed immunotherapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-023-01413-9.
format Online
Article
Text
id pubmed-10022201
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100222012023-03-18 Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo Genduso, Sandra Freytag, Vera Schetler, Daniela Kirchner, Lennart Schiecke, Alina Maar, Hanna Wicklein, Daniel Gebauer, Florian Bröker, Katharina Stürken, Christine Milde-Langosch, Karin Oliveira-Ferrer, Leticia Ricklefs, Franz L. Ewald, Florian Wolters-Eisfeld, Gerrit Riecken, Kristoffer Unrau, Ludmilla Krause, Linda Bohnenberger, Hanibal Offermann, Anne Perner, Sven Sebens, Susanne Lamszus, Katrin Diehl, Linda Linder, Stefan Jücker, Manfred Schumacher, Udo Lange, Tobias J Hematol Oncol Research BACKGROUND: The immunological composition of the tumor microenvironment has a decisive influence on the biological course of cancer and is therefore of profound clinical relevance. In this study, we analyzed the cooperative effects of integrin β4 (ITGB4) on tumor cells and E-/P-selectin on endothelial cells within the tumor stroma for regulating tumor growth by shaping the local and systemic immune environment. METHODS: We used several preclinical mouse models for different solid human cancer types (xenograft and syngeneic) to explore the role of ITGB4 (shRNA-mediated knockdown in tumor cells) and E-/P-selectins (knockout in mice) for tumor growth; effects on apoptosis, proliferation and intratumoral signaling pathways were determined by histological and biochemical methods and 3D in vitro experiments; changes in the intratumoral and systemic immune cell composition were determined by flow cytometry and immunohistochemistry; chemokine levels and their attracting potential were measured by ELISA and 3D invasion assays. RESULTS: We observed a very robust synergism between ITGB4 and E-/P-selectin for the regulation of tumor growth, accompanied by an increased recruitment of CD11b(+) Gr-1(Hi) cells with low granularity (i.e., myeloid-derived suppressor cells, MDSCs) specifically into ITGB4-depleted tumors. ITGB4-depleted tumors undergo apoptosis and actively attract MDSCs, well-known to promote tumor growth in several cancers, via increased secretion of different chemokines. MDSC trafficking into tumors crucially depends on E-/P-selectin expression. Analyses of clinical samples confirmed an inverse relationship between ITGB4 expression in tumors and number of tumor-infiltrating leukocytes. CONCLUSIONS: These findings suggest a distinct vulnerability of ITGB4(Lo) tumors for MDSC-directed immunotherapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13045-023-01413-9. BioMed Central 2023-03-17 /pmc/articles/PMC10022201/ /pubmed/36932441 http://dx.doi.org/10.1186/s13045-023-01413-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Genduso, Sandra
Freytag, Vera
Schetler, Daniela
Kirchner, Lennart
Schiecke, Alina
Maar, Hanna
Wicklein, Daniel
Gebauer, Florian
Bröker, Katharina
Stürken, Christine
Milde-Langosch, Karin
Oliveira-Ferrer, Leticia
Ricklefs, Franz L.
Ewald, Florian
Wolters-Eisfeld, Gerrit
Riecken, Kristoffer
Unrau, Ludmilla
Krause, Linda
Bohnenberger, Hanibal
Offermann, Anne
Perner, Sven
Sebens, Susanne
Lamszus, Katrin
Diehl, Linda
Linder, Stefan
Jücker, Manfred
Schumacher, Udo
Lange, Tobias
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title_full Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title_fullStr Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title_full_unstemmed Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title_short Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo
title_sort tumor cell integrin β4 and tumor stroma e-/p-selectin cooperatively regulate tumor growth in vivo
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022201/
https://www.ncbi.nlm.nih.gov/pubmed/36932441
http://dx.doi.org/10.1186/s13045-023-01413-9
work_keys_str_mv AT gendusosandra tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT freytagvera tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT schetlerdaniela tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT kirchnerlennart tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT schieckealina tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT maarhanna tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT wickleindaniel tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT gebauerflorian tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT brokerkatharina tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT sturkenchristine tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT mildelangoschkarin tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT oliveiraferrerleticia tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT ricklefsfranzl tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT ewaldflorian tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT wolterseisfeldgerrit tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT rieckenkristoffer tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT unrauludmilla tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT krauselinda tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT bohnenbergerhanibal tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT offermannanne tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT pernersven tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT sebenssusanne tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT lamszuskatrin tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT diehllinda tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT linderstefan tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT juckermanfred tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT schumacherudo tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo
AT langetobias tumorcellintegrinb4andtumorstromaepselectincooperativelyregulatetumorgrowthinvivo